Perl, Guttmacher, and Raggazoni (1956) reported that approximately one-third of patients with trichomonal vaginitis were cured after oral treatment with 2-acetylamino-5-nitrothiazole and the local application of an acid jelly. 
that approximately one-third of patients with trichomonal vaginitis were cured after oral treatment with 2-acetylamino-5-nitrothiazole and the local application of an acid jelly. In In each case a catheter specimen of urine was examined by smear and culture for Trichomonas vaginalis before treatment and on the 5th and 10th day of therapy. In two patients in the control group trichomonads were present in urine cultures taken on the 10th day.
Because of the absence of significant therapeutic effect in the dosage used, and because patients became reluctant to volunteer for oral therapy, the pilot study was abandoned.
Side-Effects of Treatment White blood cell counts, total and differential, and haemoglobin estimations were carried out before treatment and on the 5th and 10th days; no significant change was noted. One patient complained of severe abdominal pain starting on the 4th day of aminonitrothiazole, and another of headache starting on the 5th day, but both were able to complete the course of therapy. No urinary discoloration was noted.
Summary and Conclusion
Aminonitrothiazole, when given by mouth, appeared ineffective in the treatment of trichomonal vaginitis; its use is unjustified except for research under controlled conditions. We wish to thank Ortho Pharmaceutical Ltd., for supplying the 2-acetylamino-5-nitrothiazole ("Tritheon") and the control tablets of calcium lactate, Miss Joan Whittington Ph.D., for supplying the trichomonas culture medium used and Mr. K. S. G. Kendall, F.I.T.V., for undertaking the trichomonas cultures.
